U.S. Markets open in 2 hrs 23 mins

Natus Medical Incorporated (BABY)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
38.450.00 (0.00%)
At close: 4:00PM EDT
People also watch
SNHYMASIMIDDALGNCNMD

Natus Medical Incorporated

6701 Koll Center Parkway
Suite 120
Pleasanton, CA 94566
United States
925-223-6700
http://www.natus.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees1,160

Key Executives

NameTitlePayExercisedAge
Mr. James B. HawkinsPres, CEO & Director1.23MN/A61
Mr. William M. MooreCo-Founder & DirectorN/AN/A68
Mr. Jonathan A. Kennedy CPACFO, GM of Newborn Care & Exec. VP628.14k360.61k46
Mr. Kenneth M. TraversoExec. Officer365.02k125.18k56
Dr. D. Christopher Chung M.D.VP of Medical Affairs, Quality & Regulatory Affairs406.39kN/A53
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Natus Medical Incorporated provides newborn care and neurology healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. It offers diagnostic electroencephalography (EEG), ambulatory EEG, and long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, intra-operative monitoring, and diagnostic and monitoring transcranial doppler ultrasound technology systems. The company also provides hearing screening products to screen the hearing; brain injury products to diagnose the severity of brain injury; and thermoregulation products to control the incubators and warmers. In addition, it offers jaundice management products to treat jaundice; diagnostic hearing assessment products to screen for or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; NicView streaming video for families with babies in the neonatal intensive care unit; and nursery essential products used in the everyday operation of a newborn intensive care unit. Further, the company provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. The company was founded in 1987 and is headquartered in Pleasanton, California.

Corporate Governance

Natus Medical Incorporated’s ISS Governance QualityScore as of July 1, 2017 is 5. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.